Experience of headache treatment in acute non-traumatic subarachnoid hemorrhage and evaluation of treatment effectiveness

Cover Page


Cite item

Full Text

Abstract

Aim. Assessment of approaches to the identification and treatment of headache in acute non-traumatic subarachnoid hemorrhage for further study of this problem and optimization of analgesic therapy.

Methods. Medical records of 62 patients admitted to the hospital with acute non-traumatic subarachnoid hemorrhage (SAH) were retrospectively reviewed. The patients were divided into 2 groups: 19 patients underwent X-ray guided endovascular occlusion under local anesthesia and 43 patients had their aneurysm clipped under general anesthesia. Quantitative assessment of headache with the use of Visual Analog Scale (VAS) and qualitative assessment using McGill Pain Questionnaire were performed in all patients. Non-steroidal anti-inflammatory drugs (dexketoprofen, paracetamol) and opioid analgesics were used for analgesia.

Results. It was found that the wide-spread approach to the relief of headaches in SAH is not effective enough that is especially evident from the results of the second group (average VAS score in group 1 was 4.7±2.9 versus 6.3±1.8 in group 2). Achieving adequate analgesia with opioids was accompanied with excessive sedation (Richmond Agitation-Sedation Scale score was -1-2 points) complicating timely evaluation of neurological status. McGill Pain Questionnare data received and insufficient effect of the used treatment regimen allow us to suggest presence of neuropathic component of headache in non-traumatic subarachnoid hemorrhage.

Conclusion. Conventional methods and regimens of headache treatment are not effective enough so it is necessary to analyze protocol variants for headache evaluation and adequate treatment regimens considering pathogenetic mechanisms of pain in non-traumatic subarachnoid hemorrhage and the possibility of excessive sedation with opioid analgesics.

About the authors

A Zh Bayalieva

Kazan State Medical University; Interregional Clinical Diagnostic Center

Author for correspondence.
Email: ira.ganeeva@mail.ru

R Ya Shpaner

Kazan State Medical University; Interregional Clinical Diagnostic Center

Email: ira.ganeeva@mail.ru

I R Ganeeva

Kazan State Medical University; Interregional Clinical Diagnostic Center

Email: ira.ganeeva@mail.ru

References

  1. Dhakal L.P., Hodge D.O., Nagal J. et al. Safety and tolerability of gabapentin for aneurysmal Subarachnoid Hemorrhage (SAH) headache and meningismus. Neurocrit. Care. 2015; 22: 414-421. http://dx.doi.org/10.1007/s12028-014-0086-5
  2. Dhakal L.P., Harriott A.M., Capobianco D.J., Freeman W.D. Headache and its approach in today’s neurointensive care unit. Neurocrit. Care. 2016; 21: 1-15. http://dx.doi.org/10.1007/s12028-016-0260-z
  3. Lewin J.J. III, Goodwin H.E., Mirski M.A. Sedation and analgesia in critically ill neurologic patients. Neurocritical Care Society Practice Update. 2013. https://ru.scribd.com/document/246574153/06-Sedation-final (access date 02.09.2016).
  4. Linn F.H.H., Rinkel G.J.E., Algra A., Gijn van J. Headache characteristics in subarachnoid haemorrhage and benign thunderclap headache. J. Neurol. Neurosurg. Psychiatry. 1998; 65 (5): 791-793. http://dx.doi.org/10.1136/jnnp.65.5.791
  5. Mahon P., Smith B., Browne J. et al. Effective headache management in the aneurysmal subarachnoid patient: a literature review. Brit. J. Neuroscie. Nursing. 2012; 8 (2): 89-93. http://dx.doi.org/10.12968/bjnn.2012.8.2.89
  6. McMahon S.B., Koltzenburg M., Tracey I., Turk D.C. Wall & Melzack’s Textbook of Pain. London: Elsevier. 2013; 1184.
  7. Swope R., Glover K., Gokun Y. et al. Evaluation of headache severity after aneurysmal subarachnoid hemorrhage. Interdiscipl. Neurosurg. Advanced Tech. Case Manag. 2014; 1 (4): 119-122. http://dx.doi.org/10.1016/j.inat.2014.07.003

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Bayalieva A.Z., Shpaner R.Y., Ganeeva I.R.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies